News

MP4 molecule is an investigational biopharmaceutical product designed to enhance the perfusion and oxygenation of oxygen-deprived tissues and provide targeted oxygen delivery to the capillaries in severely injured

The patent entitled ‘Methods for Treatment with Bucindolol Based on Genetic Targeting,’ provides protection for this approach to treat patients with heart failure in France, Germany, Netherlands, Switzerland/Liechtenstein,

Clariant claims that the new Mevopur brand acknowledges the pharmaceutical and medical industry’s need for material consistency, reliability and change-control and can help brand owners and manufacturers minimise

SAFC’s 50,000 sqft cGMP fermentation expansion, which is expected to begin production in October 2010, will focus on niche fermentation of APIs and bulk drugs, producing secondary metabolites

As per the terms of the agreement, NovaBiotics is expected to expand its product portfolio by working with Isogenica on two research projects, one concerning peptide selection and

StemedicaAnC is expected to manufacture stem cells developed by Stemedica for the treatment of ischemic stroke and other degenerative disorders. Stemedica president and chief medical officer Nikolai Tankovich

Following the acquisition, both the companies are expected to combine their expertise in medication analytics to enhance diversion detection and clinical benchmarking that helps to ensure regulatory compliance.

Swedish Orphan Biovitrum chief scientific officer Peter Edman said that the orphan drug designation provides them with valuable regulatory support for the development of Sym001 in ITP that

Watson’s Rasagiline mesylate tablets are generic versions of Teva Neuroscience’s Azilect tablets, which are indicated for the treatment of the signs and symptoms of idiopathic Parkinson’s disease as